Structure

Physi-Chem Properties

Molecular Weight:  274.08
Volume:  270.459
LogP:  3.661
LogD:  2.452
LogS:  -3.981
# Rotatable Bonds:  0
TPSA:  86.99
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.643
Synthetic Accessibility Score:  2.804
Fsp3:  0.267
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.9
MDCK Permeability:  2.2499227270600386e-05
Pgp-inhibitor:  0.045
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.026
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.016
Plasma Protein Binding (PPB):  98.12841796875%
Volume Distribution (VD):  0.56
Pgp-substrate:  3.981147289276123%

ADMET: Metabolism

CYP1A2-inhibitor:  0.917
CYP1A2-substrate:  0.508
CYP2C19-inhibitor:  0.246
CYP2C19-substrate:  0.089
CYP2C9-inhibitor:  0.742
CYP2C9-substrate:  0.796
CYP2D6-inhibitor:  0.634
CYP2D6-substrate:  0.247
CYP3A4-inhibitor:  0.251
CYP3A4-substrate:  0.148

ADMET: Excretion

Clearance (CL):  5.691
Half-life (T1/2):  0.516

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.36
Drug-inuced Liver Injury (DILI):  0.938
AMES Toxicity:  0.563
Rat Oral Acute Toxicity:  0.255
Maximum Recommended Daily Dose:  0.285
Skin Sensitization:  0.888
Carcinogencity:  0.551
Eye Corrosion:  0.003
Eye Irritation:  0.785
Respiratory Toxicity:  0.238

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC173980

Natural Product ID:  NPC173980
Common Name*:   4,9-Dihydroxy-Alpha-Lapachone
IUPAC Name:   (4S)-4,9-dihydroxy-2,2-dimethyl-3,4-dihydrobenzo[g]chromene-5,10-dione
Synonyms:  
Standard InCHIKey:  KGIQEUTUJPXAKQ-VIFPVBQESA-N
Standard InCHI:  InChI=1S/C15H14O5/c1-15(2)6-9(17)11-12(18)7-4-3-5-8(16)10(7)13(19)14(11)20-15/h3-5,9,16-17H,6H2,1-2H3/t9-/m0/s1
SMILES:  O[C@H]1CC(C)(C)OC2=C1C(=O)c1c(C2=O)c(O)ccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL506049
PubChem CID:   44575422
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001640] Naphthopyrans
        • [CHEMONTID:0001641] Naphthopyranones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota stem bark Medicinal Plant Garden, College of Pharmacy, Ewha Womans University 2013-DEC PMID[28787158]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[9599262]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity = 60.0 % PMID[544762]
NPT2 Others Unspecified Activity = 36.1 % PMID[544762]
NPT2 Others Unspecified Activity = 88.4 % PMID[544762]
NPT2 Others Unspecified Activity = 100.0 % PMID[544762]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC173980 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9618 High Similarity NPC171968
0.9237 High Similarity NPC237225
0.9098 High Similarity NPC198305
0.9084 High Similarity NPC51037
0.9058 High Similarity NPC103337
0.9058 High Similarity NPC114620
0.8931 High Similarity NPC310540
0.8921 High Similarity NPC477408
0.8881 High Similarity NPC136878
0.8824 High Similarity NPC309430
0.8824 High Similarity NPC477406
0.8811 High Similarity NPC474630
0.8806 High Similarity NPC165257
0.8797 High Similarity NPC231774
0.8779 High Similarity NPC65627
0.8777 High Similarity NPC284184
0.8777 High Similarity NPC301341
0.8741 High Similarity NPC29932
0.8714 High Similarity NPC61590
0.8712 High Similarity NPC135062
0.8705 High Similarity NPC315275
0.8699 High Similarity NPC120171
0.8686 High Similarity NPC110609
0.8686 High Similarity NPC242358
0.8686 High Similarity NPC246693
0.8676 High Similarity NPC199253
0.8676 High Similarity NPC136588
0.8662 High Similarity NPC283292
0.8652 High Similarity NPC295339
0.8647 High Similarity NPC74507
0.8647 High Similarity NPC234890
0.863 High Similarity NPC94781
0.8623 High Similarity NPC254603
0.8623 High Similarity NPC52407
0.8613 High Similarity NPC205360
0.8611 High Similarity NPC477409
0.8611 High Similarity NPC103910
0.8592 High Similarity NPC156872
0.8571 High Similarity NPC44378
0.8571 High Similarity NPC232996
0.8571 High Similarity NPC38158
0.8571 High Similarity NPC280753
0.8562 High Similarity NPC476821
0.8551 High Similarity NPC88864
0.8551 High Similarity NPC70622
0.855 High Similarity NPC206778
0.855 High Similarity NPC285829
0.854 High Similarity NPC31799
0.8531 High Similarity NPC257003
0.8519 High Similarity NPC306765
0.8519 High Similarity NPC1991
0.8519 High Similarity NPC3224
0.8507 High Similarity NPC68756
0.8507 High Similarity NPC152525
0.8496 Intermediate Similarity NPC307174
0.8483 Intermediate Similarity NPC471906
0.8483 Intermediate Similarity NPC79627
0.8467 Intermediate Similarity NPC278928
0.8456 Intermediate Similarity NPC205918
0.8444 Intermediate Similarity NPC287473
0.8433 Intermediate Similarity NPC375356
0.8425 Intermediate Similarity NPC478160
0.8425 Intermediate Similarity NPC478019
0.8421 Intermediate Similarity NPC472889
0.8417 Intermediate Similarity NPC17843
0.8414 Intermediate Similarity NPC143898
0.8414 Intermediate Similarity NPC21873
0.8409 Intermediate Similarity NPC7151
0.8409 Intermediate Similarity NPC473662
0.8409 Intermediate Similarity NPC216297
0.8406 Intermediate Similarity NPC27659
0.8403 Intermediate Similarity NPC110810
0.8392 Intermediate Similarity NPC299405
0.8392 Intermediate Similarity NPC471602
0.8392 Intermediate Similarity NPC29771
0.8392 Intermediate Similarity NPC216312
0.8392 Intermediate Similarity NPC476477
0.8392 Intermediate Similarity NPC111422
0.8392 Intermediate Similarity NPC306835
0.8392 Intermediate Similarity NPC256463
0.8382 Intermediate Similarity NPC96915
0.8382 Intermediate Similarity NPC81135
0.838 Intermediate Similarity NPC305060
0.8378 Intermediate Similarity NPC112816
0.8369 Intermediate Similarity NPC281513
0.8369 Intermediate Similarity NPC22222
0.8367 Intermediate Similarity NPC285122
0.8358 Intermediate Similarity NPC164947
0.8358 Intermediate Similarity NPC300274
0.8357 Intermediate Similarity NPC193169
0.8357 Intermediate Similarity NPC59459
0.8356 Intermediate Similarity NPC475201
0.8345 Intermediate Similarity NPC469520
0.8345 Intermediate Similarity NPC474300
0.8345 Intermediate Similarity NPC93015
0.8333 Intermediate Similarity NPC220496
0.8333 Intermediate Similarity NPC42262
0.8333 Intermediate Similarity NPC91809
0.8333 Intermediate Similarity NPC241349
0.8333 Intermediate Similarity NPC37992
0.8333 Intermediate Similarity NPC32749
0.8333 Intermediate Similarity NPC34414
0.8333 Intermediate Similarity NPC327916
0.8333 Intermediate Similarity NPC147542
0.8333 Intermediate Similarity NPC146647
0.8322 Intermediate Similarity NPC84142
0.8322 Intermediate Similarity NPC474310
0.8311 Intermediate Similarity NPC472135
0.831 Intermediate Similarity NPC86524
0.831 Intermediate Similarity NPC474311
0.8309 Intermediate Similarity NPC103540
0.8298 Intermediate Similarity NPC50924
0.8289 Intermediate Similarity NPC170189
0.8289 Intermediate Similarity NPC314257
0.8289 Intermediate Similarity NPC208173
0.8288 Intermediate Similarity NPC478164
0.8288 Intermediate Similarity NPC469885
0.8288 Intermediate Similarity NPC476473
0.8286 Intermediate Similarity NPC478190
0.8278 Intermediate Similarity NPC115249
0.8276 Intermediate Similarity NPC471444
0.8276 Intermediate Similarity NPC305845
0.8276 Intermediate Similarity NPC204045
0.8273 Intermediate Similarity NPC475741
0.8273 Intermediate Similarity NPC117609
0.8273 Intermediate Similarity NPC55949
0.8267 Intermediate Similarity NPC164762
0.8264 Intermediate Similarity NPC190457
0.8261 Intermediate Similarity NPC247250
0.8261 Intermediate Similarity NPC767
0.8261 Intermediate Similarity NPC282923
0.8258 Intermediate Similarity NPC41567
0.8255 Intermediate Similarity NPC142846
0.8244 Intermediate Similarity NPC108288
0.8243 Intermediate Similarity NPC300540
0.8239 Intermediate Similarity NPC80035
0.8235 Intermediate Similarity NPC142956
0.8231 Intermediate Similarity NPC89664
0.8231 Intermediate Similarity NPC244691
0.8231 Intermediate Similarity NPC274085
0.8227 Intermediate Similarity NPC225051
0.8227 Intermediate Similarity NPC314048
0.8227 Intermediate Similarity NPC263817
0.8224 Intermediate Similarity NPC137301
0.8224 Intermediate Similarity NPC312482
0.8224 Intermediate Similarity NPC155686
0.8219 Intermediate Similarity NPC135524
0.8219 Intermediate Similarity NPC308572
0.8217 Intermediate Similarity NPC470735
0.8217 Intermediate Similarity NPC329647
0.8214 Intermediate Similarity NPC205992
0.8214 Intermediate Similarity NPC244699
0.8214 Intermediate Similarity NPC477412
0.8212 Intermediate Similarity NPC46882
0.8212 Intermediate Similarity NPC132990
0.8201 Intermediate Similarity NPC99731
0.82 Intermediate Similarity NPC77325
0.82 Intermediate Similarity NPC4423
0.8195 Intermediate Similarity NPC232178
0.8194 Intermediate Similarity NPC284495
0.8188 Intermediate Similarity NPC252208
0.8188 Intermediate Similarity NPC471530
0.8188 Intermediate Similarity NPC470841
0.8188 Intermediate Similarity NPC478018
0.8182 Intermediate Similarity NPC141934
0.8182 Intermediate Similarity NPC155211
0.8182 Intermediate Similarity NPC317900
0.8182 Intermediate Similarity NPC246466
0.8182 Intermediate Similarity NPC476404
0.8182 Intermediate Similarity NPC294300
0.8182 Intermediate Similarity NPC29552
0.8176 Intermediate Similarity NPC170055
0.8176 Intermediate Similarity NPC28632
0.8175 Intermediate Similarity NPC123506
0.817 Intermediate Similarity NPC478133
0.817 Intermediate Similarity NPC472890
0.817 Intermediate Similarity NPC69043
0.817 Intermediate Similarity NPC478230
0.817 Intermediate Similarity NPC478221
0.817 Intermediate Similarity NPC317585
0.8169 Intermediate Similarity NPC44437
0.8169 Intermediate Similarity NPC474097
0.8169 Intermediate Similarity NPC202225
0.8158 Intermediate Similarity NPC470340
0.8158 Intermediate Similarity NPC184284
0.8158 Intermediate Similarity NPC478224
0.8158 Intermediate Similarity NPC76041
0.8156 Intermediate Similarity NPC477407
0.8151 Intermediate Similarity NPC149533
0.8146 Intermediate Similarity NPC472891
0.8143 Intermediate Similarity NPC147757
0.8141 Intermediate Similarity NPC478134
0.8138 Intermediate Similarity NPC26924
0.8133 Intermediate Similarity NPC470479
0.8129 Intermediate Similarity NPC48248
0.8129 Intermediate Similarity NPC179898
0.8125 Intermediate Similarity NPC264022
0.8125 Intermediate Similarity NPC471452
0.8125 Intermediate Similarity NPC475957
0.8125 Intermediate Similarity NPC53414

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC173980 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8309 Intermediate Similarity NPD1470 Approved
0.8244 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.8056 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8015 Intermediate Similarity NPD1201 Approved
0.7703 Intermediate Similarity NPD2346 Discontinued
0.7687 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7682 Intermediate Similarity NPD3300 Phase 2
0.7613 Intermediate Similarity NPD3226 Approved
0.7584 Intermediate Similarity NPD1471 Phase 3
0.7582 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD1510 Phase 2
0.7533 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD8150 Discontinued
0.7463 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD4380 Phase 2
0.7417 Intermediate Similarity NPD1549 Phase 2
0.7415 Intermediate Similarity NPD943 Approved
0.7403 Intermediate Similarity NPD7390 Discontinued
0.74 Intermediate Similarity NPD2935 Discontinued
0.7397 Intermediate Similarity NPD2313 Discontinued
0.7355 Intermediate Similarity NPD2533 Approved
0.7355 Intermediate Similarity NPD2534 Approved
0.7355 Intermediate Similarity NPD2532 Approved
0.7351 Intermediate Similarity NPD2344 Approved
0.7351 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7319 Intermediate Similarity NPD9493 Approved
0.7315 Intermediate Similarity NPD1607 Approved
0.7312 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD7819 Suspended
0.7308 Intermediate Similarity NPD1512 Approved
0.7297 Intermediate Similarity NPD1240 Approved
0.7285 Intermediate Similarity NPD5408 Approved
0.7285 Intermediate Similarity NPD5404 Approved
0.7285 Intermediate Similarity NPD5405 Approved
0.7285 Intermediate Similarity NPD5406 Approved
0.7284 Intermediate Similarity NPD7075 Discontinued
0.7267 Intermediate Similarity NPD5402 Approved
0.7256 Intermediate Similarity NPD6959 Discontinued
0.7254 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD1934 Approved
0.725 Intermediate Similarity NPD6801 Discontinued
0.7246 Intermediate Similarity NPD3751 Discontinued
0.7241 Intermediate Similarity NPD2798 Approved
0.7235 Intermediate Similarity NPD4955 Approved
0.7235 Intermediate Similarity NPD36 Approved
0.7235 Intermediate Similarity NPD5026 Approved
0.7235 Intermediate Similarity NPD5028 Approved
0.7235 Intermediate Similarity NPD4954 Approved
0.7235 Intermediate Similarity NPD5034 Approved
0.7226 Intermediate Similarity NPD7236 Approved
0.7222 Intermediate Similarity NPD3882 Suspended
0.7212 Intermediate Similarity NPD6232 Discontinued
0.7205 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7473 Discontinued
0.7179 Intermediate Similarity NPD1511 Approved
0.7176 Intermediate Similarity NPD5030 Phase 2
0.7172 Intermediate Similarity NPD1164 Approved
0.7171 Intermediate Similarity NPD2796 Approved
0.717 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD2309 Approved
0.7134 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD447 Suspended
0.7126 Intermediate Similarity NPD6166 Phase 2
0.7126 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD6534 Approved
0.7119 Intermediate Similarity NPD6535 Approved
0.7113 Intermediate Similarity NPD2932 Approved
0.7111 Intermediate Similarity NPD6781 Approved
0.7111 Intermediate Similarity NPD9266 Approved
0.7111 Intermediate Similarity NPD6778 Approved
0.7111 Intermediate Similarity NPD6782 Approved
0.7111 Intermediate Similarity NPD6780 Approved
0.7111 Intermediate Similarity NPD6776 Approved
0.7111 Intermediate Similarity NPD6779 Approved
0.7111 Intermediate Similarity NPD74 Approved
0.7111 Intermediate Similarity NPD6777 Approved
0.7105 Intermediate Similarity NPD2799 Discontinued
0.7101 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD2801 Approved
0.7097 Intermediate Similarity NPD3750 Approved
0.7088 Intermediate Similarity NPD7435 Discontinued
0.7083 Intermediate Similarity NPD9717 Approved
0.7073 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD5038 Approved
0.7069 Intermediate Similarity NPD8434 Phase 2
0.7069 Intermediate Similarity NPD5037 Approved
0.7068 Intermediate Similarity NPD1237 Approved
0.7055 Intermediate Similarity NPD3817 Phase 2
0.7055 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD1203 Approved
0.7051 Intermediate Similarity NPD6190 Approved
0.7047 Intermediate Similarity NPD411 Approved
0.7047 Intermediate Similarity NPD3764 Approved
0.7044 Intermediate Similarity NPD5403 Approved
0.7042 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD3818 Discontinued
0.7037 Intermediate Similarity NPD9263 Approved
0.7037 Intermediate Similarity NPD9264 Approved
0.7037 Intermediate Similarity NPD6844 Discontinued
0.7037 Intermediate Similarity NPD9267 Approved
0.7032 Intermediate Similarity NPD2800 Approved
0.7025 Intermediate Similarity NPD5401 Approved
0.7019 Intermediate Similarity NPD6599 Discontinued
0.7018 Intermediate Similarity NPD6797 Phase 2
0.7011 Intermediate Similarity NPD5036 Approved
0.7 Intermediate Similarity NPD7239 Suspended
0.7 Intermediate Similarity NPD7699 Phase 2
0.7 Intermediate Similarity NPD7700 Phase 2
0.6995 Remote Similarity NPD7696 Phase 3
0.6995 Remote Similarity NPD7698 Approved
0.6995 Remote Similarity NPD7697 Approved
0.6994 Remote Similarity NPD8312 Approved
0.6994 Remote Similarity NPD8313 Approved
0.6993 Remote Similarity NPD4308 Phase 3
0.6993 Remote Similarity NPD3019 Approved
0.6977 Remote Similarity NPD7251 Discontinued
0.6972 Remote Similarity NPD9545 Approved
0.697 Remote Similarity NPD3749 Approved
0.6962 Remote Similarity NPD6799 Approved
0.6957 Remote Similarity NPD7871 Phase 2
0.6957 Remote Similarity NPD8320 Phase 1
0.6957 Remote Similarity NPD8319 Approved
0.6957 Remote Similarity NPD7870 Phase 2
0.6948 Remote Similarity NPD1551 Phase 2
0.6946 Remote Similarity NPD1247 Approved
0.6936 Remote Similarity NPD7808 Phase 3
0.6936 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6908 Remote Similarity NPD230 Phase 1
0.6908 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6903 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6901 Remote Similarity NPD5844 Phase 1
0.6893 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6887 Remote Similarity NPD6663 Approved
0.6887 Remote Similarity NPD520 Approved
0.6886 Remote Similarity NPD5494 Approved
0.6884 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6883 Remote Similarity NPD7033 Discontinued
0.6879 Remote Similarity NPD8166 Discontinued
0.6879 Remote Similarity NPD4628 Phase 3
0.6879 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6273 Approved
0.6875 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6872 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6872 Remote Similarity NPD6213 Phase 3
0.6872 Remote Similarity NPD6212 Phase 3
0.6871 Remote Similarity NPD7411 Suspended
0.6862 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6862 Remote Similarity NPD7874 Approved
0.6846 Remote Similarity NPD5736 Approved
0.6846 Remote Similarity NPD9494 Approved
0.6845 Remote Similarity NPD7701 Phase 2
0.6839 Remote Similarity NPD6099 Approved
0.6839 Remote Similarity NPD6100 Approved
0.6832 Remote Similarity NPD920 Approved
0.6826 Remote Similarity NPD919 Approved
0.6821 Remote Similarity NPD3268 Approved
0.6809 Remote Similarity NPD9281 Approved
0.6805 Remote Similarity NPD3787 Discontinued
0.6805 Remote Similarity NPD5711 Approved
0.6805 Remote Similarity NPD5710 Approved
0.6802 Remote Similarity NPD7054 Approved
0.68 Remote Similarity NPD6832 Phase 2
0.68 Remote Similarity NPD5035 Approved
0.6788 Remote Similarity NPD5760 Phase 2
0.6788 Remote Similarity NPD5761 Phase 2
0.6782 Remote Similarity NPD6559 Discontinued
0.6782 Remote Similarity NPD5027 Approved
0.6782 Remote Similarity NPD5029 Approved
0.6782 Remote Similarity NPD5031 Approved
0.6779 Remote Similarity NPD1019 Discontinued
0.6774 Remote Similarity NPD3748 Approved
0.6772 Remote Similarity NPD7003 Approved
0.6763 Remote Similarity NPD7472 Approved
0.6763 Remote Similarity NPD7074 Phase 3
0.6757 Remote Similarity NPD1283 Approved
0.6757 Remote Similarity NPD1876 Approved
0.6748 Remote Similarity NPD7458 Discontinued
0.6741 Remote Similarity NPD9261 Approved
0.6738 Remote Similarity NPD1241 Discontinued
0.6737 Remote Similarity NPD7801 Approved
0.6735 Remote Similarity NPD3972 Approved
0.6732 Remote Similarity NPD4307 Phase 2
0.6732 Remote Similarity NPD4060 Phase 1
0.6725 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6723 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6711 Remote Similarity NPD2797 Approved
0.6708 Remote Similarity NPD642 Clinical (unspecified phase)
0.6708 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6707 Remote Similarity NPD7058 Phase 2
0.6707 Remote Similarity NPD7768 Phase 2
0.6707 Remote Similarity NPD7057 Phase 3
0.6707 Remote Similarity NPD4868 Clinical (unspecified phase)
0.669 Remote Similarity NPD1651 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data